mucosal immunity

TWiV 655: Minority health with Robert Fullilove

Sociomedical scientist Robert Fullilove joins TWiV to discuss disparities in minority health; FDA announces an EUA on Yale’s SalivaDirect, protection of the upper and respiratory tract of mice after intranasal inoculation with an adenovirus-vectored SARS-CoV-2 spike gene, and listener questions. Click arrow to playDownload TWiV 655 (88 MB .mp3, 147 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show …

TWiV 655: Minority health with Robert Fullilove Read More »

Whole plant cells producing viral capsid protein as a poliovirus vaccine candidate

Although the use of the live, attenuated (Sabin) poliovirus vaccines has been instrumental in nearly eradicating the virus from the planet, the rare reversion to virulence of these strains has lead to the World Health Organization to recommend their replacement with inactivated poliovirus vaccine (IPV). Unfortunately IPV is also not without shortcomings, including high cost, failure …

Whole plant cells producing viral capsid protein as a poliovirus vaccine candidate Read More »

TWiV #356: Got viruses?

On episode #356 of the science show This Week in Virology, Stephanie joins the super professors to discuss the gut virome of children with serious malnutrition, caterpillar genes acquired from parasitic wasps, and the effect of adding chemokines to a simian immunodeficiency virus DNA vaccine. You can find TWiV #356 at www.microbe.tv/twiv.

An unexpected benefit of inactivated poliovirus vaccine

The polio eradication and endgame strategic plan announced by the World Health Organization in 2014 includes at least one dose of inactivated poliovirus vaccine (IPV). Since 1988, when WHO announced the polio eradication plan, it had relied exclusively on the use of oral poliovirus vaccine (OPV). The rationale for including a dose of IPV was …

An unexpected benefit of inactivated poliovirus vaccine Read More »

Scroll to Top